NDC 11673-198 – Motion Sickness

Dimenhydrinate 50 mg/1 · Tablet · Oral

Human Otc Drug

Product NDC11673-198

Product details

Brand name
Motion Sickness
Generic name
Dimenhydrinate
Labeler
Target Corporation
Dosage form
Tablet
Route
Oral
Marketing category
OTC MONOGRAPH DRUG · M009
Marketed since
December 1, 1992
Marketing end
October 31, 2027
Pharmacologic class
Histamine-1 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Motion Sickness →

Package NDC codes (2)

Package NDCDescriptionSince
11673-198-022 BLISTER PACK in 1 CARTON (11673-198-02) / 6 TABLET in 1 BLISTER PACKDec 1, 1992
11673-198-084 BLISTER PACK in 1 CARTON (11673-198-08) / 6 TABLET in 1 BLISTER PACKDec 1, 1992

Other Motion Sickness products